Status:
COMPLETED
Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease
Lead Sponsor:
Boston Children's Hospital
Conditions:
Congenital Heart Disease
Heart Defects, Congenital
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The hypothesis of this study is that participation in a formal cardiopulmonary rehabilitation program improves aerobic exercise capacity and quality of life over the medium term for patients with cong...
Eligibility Criteria
Inclusion
- Able and willing to participate in a 12-week cardiac rehabilitation program and repeated cardiopulmonary exercise testing
- pVO2≤80% predicted (impaired aerobic capacity) on baseline exercise test
- congenital heart disease of at least moderate complexity
Exclusion
- Cardiac intervention (cath/surg) within prior 6m
- Planned cardiac intervention (cath/surg) within 12m
- Formal cardiac rehabilitation within 24m
- Current/recent (delivery\<90d prior) pregnancy, planned pregnancy within 12m
- Active heart failure, hospitalization or major change in clinical status over prior 30d
- Other recent or planned events expected to have a significant impact on exercise capacity
- Baseline oxygen saturation \<92%
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01822769
Start Date
April 1 2013
End Date
December 1 2017
Last Update
January 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115